Scaffold Hopping of α-Rubromycin Enables Direct Access to FDA-Approved Cromoglicic Acid as a SARS-CoV-2 MPro Inhibitor
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Scaffold Hopping of α-Rubromycin Enables Direct Access to FDA-Approved Cromoglicic Acid as a SARS-CoV-2 MPro Inhibitor
Authors
Keywords
-
Journal
Pharmaceuticals
Volume 14, Issue 6, Pages 541
Publisher
MDPI AG
Online
2021-06-07
DOI
10.3390/ph14060541
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Protein structural heterogeneity: A hypothesis for the basis of proteolytic recognition by the main protease of SARS-CoV and SARS-CoV-2
- (2021) Mira A.M. Behnam BIOCHIMIE
- Role of ivermectin in the prevention of SARS-CoV-2 infection among healthcare workers in India: A matched case-control study
- (2021) Priyamadhaba Behera et al. PLoS One
- Benchmark of Popular Free Energy Approaches Revealing the Inhibitors Binding to SARS-CoV-2 Mpro
- (2021) Son Tung Ngo et al. Journal of Chemical Information and Modeling
- Expedited Approach toward the Rational Design of Noncovalent SARS-CoV-2 Main Protease Inhibitors
- (2021) Naoya Kitamura et al. JOURNAL OF MEDICINAL CHEMISTRY
- Repurposing Anti-Malaria Phytomedicine Artemisinin as a COVID-19 Drug
- (2021) Fatih M. Uckun et al. Frontiers in Pharmacology
- Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
- (2020) Zhenming Jin et al. NATURE
- Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease
- (2020) Wenhao Dai et al. SCIENCE
- Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
- (2020) Linlin Zhang et al. SCIENCE
- Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19
- (2020) Khan Sharun et al. Annals of Clinical Microbiology and Antimicrobials
- The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
- (2020) Leon Caly et al. ANTIVIRAL RESEARCH
- Dexamethasone in the management of covid -19
- (2020) Raymond M Johnson et al. BMJ-British Medical Journal
- Anti-SARS-CoV-2 Potential of Artemisinins In Vitro
- (2020) Ruiyuan Cao et al. ACS Infectious Diseases
- Microbial Natural Products as Potential Inhibitors of SARS-CoV-2 Main Protease (Mpro)
- (2020) Ahmed M. Sayed et al. Microorganisms
- The SARS-CoV-2 main protease as drug target
- (2020) Sven Ullrich et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Drug repurposing approach to fight COVID-19
- (2020) Thakur Uttam Singh et al. Pharmacological Reports
- Exploring the Mechanism of Covalent Inhibition: Simulating the Binding Free Energy of α-Ketoamide Inhibitors of the Main Protease of SARS-CoV-2
- (2020) Dibyendu Mondal et al. BIOCHEMISTRY
- Repurposing of some anti‐infective drugs for COVID‐19 treatment: A surveillance study supported by an in silico investigation
- (2020) Ahmed M. Sayed et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Potential association of mast cells with coronavirus disease 2019
- (2020) Theoharis C. Theoharides ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Ensemble Docking in Drug Discovery
- (2018) Rommie E. Amaro et al. BIOPHYSICAL JOURNAL
- CLC-Pred: A freely available web-service for in silico prediction of human cell line cytotoxicity for drug-like compounds
- (2018) Alexey A. Lagunin et al. PLoS One
- Conf-VLKA: A structure-based revisitation of the Virtual Lock-and-key Approach
- (2017) Marco Tutone et al. JOURNAL OF MOLECULAR GRAPHICS & MODELLING
- SwissSimilarity: A Web Tool for Low to Ultra High Throughput Ligand-Based Virtual Screening
- (2016) Vincent Zoete et al. Journal of Chemical Information and Modeling
- Isolation, biological activity, biosynthesis and synthetic studies towards the rubromycin family of natural products
- (2015) Darcy J. Atkinson et al. NATURAL PRODUCT REPORTS
- The immunology of asthma
- (2015) Bart N Lambrecht et al. NATURE IMMUNOLOGY
- Ligand docking and binding site analysis with PyMOL and Autodock/Vina
- (2010) Daniel Seeliger et al. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
- New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays
- (2010) Jonathan B. Baell et al. JOURNAL OF MEDICINAL CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now